Search results :


More information: STITCH, PubChem and possibly Wikipedia

ATC Code: B01AC22

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4
Hypertension Hypertension 7.1% - 7.5% x x x
Hypercholesterolaemia Hypercholesterolaemia 7% - 7.4% x x x
Hyperlipidaemia Hyperlipidaemia 7% - 7.4% x x x
Headache Headache 5.3% - 5.5% x x x
Back pain Back pain 4.5% - 5% x x x
Dyspnoea Dyspnoea 4.5% - 4.9% x x x
Nausea Nausea 4.3% - 4.6% x x x
Dizziness Dizziness 4.1% - 4.6% x x x
Asthenia Fatigue 3.7% - 4.8% x x x
Fatigue Fatigue 3.7% - 4.8% x x x
Cough Cough 3.9% - 4.1% x x x
Hypotension Hypotension 3.8% - 3.9% x x x
Non-cardiac chest pain Non-cardiac chest pain 3.1% - 3.5% x x x
Leukopenia Leukopenia 2.8% - 3.5% x x x
Atrial fibrillation Atrial fibrillation 2.9% - 3.1% x x x
Oedema peripheral Oedema peripheral 2.7% - 3% x x x
Bradycardia Bradycardia 2.4% - 2.9% x x x
Dermatitis Rash 2.4% - 2.8% x x x x
Rash Rash 2.4% - 2.8% x x x x
Pain in extremity Pain in extremity 2.6% x x x
Diarrhoea Diarrhoea 2.3% - 2.6% x x x
Body temperature increased Body temperature increased 2.2% - 2.7% x x x
Haemorrhage Haemorrhage 0.5% - 14.1% x x x x
Haemoglobin Haemorrhage 0.5% - 14.1% x x x x
Surgery Surgical intervention 0.1% - 0.4% x x x x
Anaphylactic shock Anaphylactic shock postmarketing x
Angioedema Angioedema rare x x x x
Hypersensitivity Hypersensitivity postmarketing — 0.36% x x x x
Immune system disorder Immune system disorder postmarketing x x
Thrombocytopenia Thrombocytopenia postmarketing x x x x
Cerebrovascular accident Cerebrovascular accident 0.005% - 0.054% x x
Thrombotic thrombocytopenic purpura Thrombotic thrombocytopenic purpura very rare, postmarketing x x x
Anaemia Anaemia x x x x
Neoplasm malignant Neoplasm malignant x
Contusion Contusion x x x
Ecchymosis Ecchymosis x x x
Epistaxis Epistaxis x x x x
Eye disorder Eye disorder x x x
Eye haemorrhage Eye haemorrhage x x x
Gastrointestinal disorder Gastrointestinal disorder x
Gastrointestinal haemorrhage Gastrointestinal haemorrhage x x x x
Gingival bleeding Gingival bleeding x x x
Haematochezia Haematochezia x x x
Haematoma Haematoma x x x
Haematuria Haematuria x x x
Haemoptysis Haemoptysis x x x x
Mediastinal disorder Mediastinal disorder x x x
Neoplasm Neoplasm x x
Pericardial effusion Pericardial effusion x
Retinal haemorrhage Retinal haemorrhage x
Urethral disorder Urinary tract disorder x x x
Urinary tract disorder Urinary tract disorder x x x
Angiopathy Angiopathy x x x
Haemorrhage intracranial Haemorrhage intracranial 0% - 0.3% x x x x
Retroperitoneal haemorrhage Retroperitoneal haemorrhage x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x x x
Rectal haemorrhage Rectal haemorrhage x x x
Subcutaneous haematoma Subcutaneous haematoma x x x x
Thrombocytopenic purpura Thrombocytopenic purpura x
Post procedural haemorrhage Post procedural haemorrhage x x x x
Puncture site haemorrhage Puncture site haemorrhage x x x
Colorectal cancer Colorectal cancer x
Vessel puncture site haematoma Vessel puncture site haematoma x x


Information about indications was extracted from the indications and usage sections of the labels.

prasugrel / prasugrel

Side effects:32


Side effects:40
Source:FDA Structured Product Label

EFFIENT (prasugrel hydrochloride) / EFFIENT

Side effects:51

Color scheme:


    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    no frequency information
    not found on label